Actively Recruiting
One Stage Ridge Splitting Using 2 Different Techniques in the Posterior Mandible
Led by Cairo University · Updated on 2025-07-16
20
Participants Needed
1
Research Sites
35 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The selected patients will be informed of the nature of the research work and informed consent will be obtained. The control group ridge splitting with simultaneous implants using the conventional technique and study group ridge splitting with simultaneous implants using the piezo surgery. * Pre operative procedures Patients of both groups will be subjected to CBCT. * Intra operative procedures (for both groups) followed by CBCT will be taken for every patient after 4 months. * Infiltration local anesthesia will be given to the patient (Articaine 4% 1:100 000 epinephrine). Both the study and control group will receive: * In Recipient site, incision of full thickness mucoperiosteal flap inorder to obtain, three-line pyramidal flap, followed by flap reflection. * The defective site is reevaluated. * Flap advancement using periosteal releasing incision. * In the Study group: Piezo surgery bone inserts are used. * In the Control group: Bone discs diameter are used. * Followed by bone chisels. * The point and pilot implant drills are used followed by the sequential use of bone expanders. Based on the preexisting bone, the defect morphology and bone quality. The implant is submerged below the alveolar crest. * The fixture is inserted submerged below the alveolar bone crest followed by bone smoothening and roundation under external saline irrigation at recommended speed of 38000rpm and gear ratio 1:1 calibrated on fesiodespenser. * Xenogenic bone particle size of 0.5 mm to 1mm is going to be condensed into the dead space. * Recheck adequate flap advancement. * Double line closure using horizontal mattress sutures followed by interrupted sutures on top to allow contact area and wound edge eversion.
CONDITIONS
Official Title
One Stage Ridge Splitting Using 2 Different Techniques in the Posterior Mandible
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with mandibular residual alveolar bone height not less than 8 mm.
- Alveolar bone width from 3 mm to 5 mm.
- Both genders.
- At least a single missing tooth.
- Previous failed implants.
- Tapered or cylinder cross-sectioned alveolar bone defect pattern.
You will not qualify if you...
- Heavy smokers more than 20 cigarettes per day.
- Patients with bone diseases affecting healing, such as hyperparathyroidism.
- Patients who had radiotherapy or chemotherapy in the head and neck region.
- Patients with tumors in the grafted sites.
- Patients with uncontrolled metabolic diseases, including diabetes with Hb A1c over 7 mg/dl.
- Pregnant females.
- Patients with parafunctional habits, those apprehensive or non-cooperative.
- Bone pathology related to the graft site.
- Psychological problems, stress, emotional instability, or unrealistic expectations.
- Intraoral soft and hard tissue pathology.
- Systemic conditions contraindicating implant placement.
- Under 18 years of age.
- Hourglass defects or defects with bone concavities or undercuts.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Dentistry Cairo University
Cairo, Egypt, 11553
Actively Recruiting
Research Team
M
Mohannad A. Ismail, MSc.
CONTACT
A
Ahmed M Youssef, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here